Interactions of cadmium compounds with endogenous iron in the intestinal tract.
Sugawara
N
N
Department of Public Health, Sapporo Medical College, Japan.
Sugawara
C
C
D000284:Administration, Oral; D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D001667:Binding, Competitive; D002104:Cadmium / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics*; D019256:Cadmium Chloride; D004305:Dose-Response Relationship, Drug; D007279:Injections, Subcutaneous; D007421:Intestine, Small / Q000378:metabolism*; D007501:Iron / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008297:Male; D008668:Metallothionein / Q000378:metabolism; D051379:Mice; D008813:Mice, Inbred ICR; D013997:Time Factors
D002104:Cadmium; D008668:Metallothionein; D007501:Iron; D000469:Alkaline Phosphatase; D019256:Cadmium Chloride